key: cord-0782296-2rqefxyy
authors: NEJAD BIGLARI, Habibeh; SINAEI, Reza; PEZESHKI, Sara; KHAJEH HASANI, Fatemeh
title: Acute transverse myelitis of childhood due to novel coronavirus disease 2019: The first pediatric case report and review of literature
date: 2021
journal: Iran J Child Neurol
DOI: 10.22037/ijcn.v15i1.31579
sha: d5349f95adc382534c7a0e574926ffb1b3f0a5ed
doc_id: 782296
cord_uid: 2rqefxyy

The global coronavirus disease 2019 (COVID-19) pandemic appears to have some streaks of severity in pediatrics. These streaks include variable signs of respiratory distress, a new entity called multi-system inflammatory syndrome, and some evidences of neurological symptoms involving both central and peripheral nervous systems. Here, we described the first pediatric patient with COVID-19 who presented with acute transverse myelitis. An 11-year-old otherwise healthy girl presented to our clinic with acute onset of lower limbs paresis, urinary and fecal retention, alongside epigastric pain, and fever for 3 days. A neurological examination revealed a severe flaccid paraplegia in her lower limbs associated with a sensory level at T5. She was evaluated systematically for all probable causes of her symptoms, and finally, due to having a positive nasopharyngeal PCR test, she was considered to suffer from post-COVID-19 transverse myelitis. She underwent intravenous-immunoglobulin, methylprednisolone pulse, and other supportive cares without obvious results. Therefore, she underwent seven sessions of plasma exchange with little effects on muscle strength. The focal inflammation and injury of the spinal cord, otherwise known as transverse myelitis, have a wide array of potential etiologies. Transverse myelitis has been well documented to be the result of viral and bacterial infections. We believe our patient was not involved in a cytokine storm status due to good CRP, IL-6 and Ferritin levels. Albeit, we cannot certainly consider the patient to have a direct viral impactor involved in a late immunity process. To our knowledge, this is the first report of TM in the field of pediatrics occurred after COVID-19. Thus, this is critical to note that children can present with some severe types of COVID-19.

The global COVID-19 pandemic initially appeared to have milder courses in pediatrics. Since the last few weeks, there have been some streaks of severity in pediatric age reports, characterized by persistent fever, shock, myocarditis, and variable signs of a new entity called multi-system inflammatory syndrome (MIS-C) (1) . Moreover, children with COVID-19-related MIS-C may experience neurological symptoms that involve both the central and peripheral nervous systems (CNS and PNS). In a case series of four pediatric patients with COVID-19 and neurological-related symptoms, encephalopathy, headache, brain stem and cerebellar signs, muscle weakness, and reduced reflexes were reported. All the patients had signal changes in the splenium of corpus callosum on neuroimaging in the absence of respiratory symptoms (2).

Since severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)enters cells via the angiotensin-converting enzyme 2 (ACE-2) receptor, and given that ACE-2 is expressed in both neurons and glial cells, a direct viral invasion of CNS may be a probable mechanism for neurological manifestations of COVID-19

(3). However, only vascular cells and not neurons express ACE-2 in the brain; thus this potentially contributes to dissemination of virus into the brain by blood circulation (4) . Albeit, an immunemediated neuronal syndrome has been recently proposed in some adult neurological reports (5) . Here, we reported an 11-year-old girl who presented with new-onset neurological symptoms and neurological imaging findings identic with the diagnosis of acute transverse myelitis associated with COVID-19.

An 11-year-old otherwise healthy girl presented to our clinic with acute onset of lower limbs paresis, weakness, and urinary and fecal retention. (3) . Furthermore, in advanced stages of the disease, neurological findings could be due to the effect of hypoxia sequels as well as respiratory and metabolic acidosis (4) . However, the precise mechanism of the disease is unclear, and like in most post-infectious TM, an immune-mediated pathogenesis may be involved (8) . We believe our patient was not involved in a cytokine storm status due to good CRP, IL-6 and Ferritin levels. Albeit, we cannot certainly consider whether the patient had a direct viral neurological impact or a delayed immunity phenomenon were happened, just like what happens in multi system inflammatory of childhood (MIS-C). We do not have PCR from CSF or some auto-antibodies as complementary parameters, and this appears to be the first pediatric post-coronavirus TM report. The patient's medical file could be further investigated for NOM and other possibilities that we could not exclude despite our comprehensive systematic evaluation.

Childhood Multisystem Inflammatory Syndrome-A New Challenge in the Pandemic

Neurologic and radiographic findings associated with COVID-19 infection in children

Acute myelitis after SARS-CoV-2 infection: a case report

Acute Myelitis as a Neurological Complication ofCovid-19: A Case Report and MRI Findings

Miller Fisher Syndrome and polyneuritis cranialis in COVID-19

A Case Report of Acute Transverse Myelitis Following Novel Coronavirus Infection. Clinical Practice and Cases in

Idiopathic transverse myelitis: observations from 60 clinical cases at UAB

Transverse myelitis related to COVID-19 infection

We would like to thank all the staff of the